Golden Helix Blog

Customer Publications March 2020: Spotlight on Congenital Defects and Early Development

Mar 31, 2020

In these very uncertain times, it has been uplifting to read the wonderful work Golden Helix customers have been doing across the globe! In March 2020, the focus of this blog is on published articles relating to congenital defects and early development. Congratulations to all our customers who have published…

Read more →

COVID-19 Remote Assistance Program for Golden Helix Users

Mar 13, 2020

At Golden Helix, customer support is our number one priority. This commitment extends beyond technical assistance—it includes the health, safety, and overall well-being of our entire community. During this time of global uncertainty, we want to first acknowledge the incredible dedication of healthcare professionals and frontline workers around the world.…

Read more →

Golden Helix Named as Top 10 World’s Most Trust Worthy Bioanalysis Companies in 2020

Mar 13, 2020

We’re thrilled to share that Golden Helix has been recognized by CIO Look as one of the Top 10 Most Trustworthy Bioanalysis Companies in the World. This recognition highlights our dedication to supporting clinical labs and healthcare organizations with cutting-edge, affordable, and reliable software solutions for genomic data analysis. For…

Read more →

Updated VSReports Project Templates

Mar 10, 2020

Generating a clinical report is the final step of most NGS pipelines and is important as it relays results and information to legacy systems, physicians and ultimately the patient. Golden Helix’s clinical reporting capabilities are designed to integrate seamlessly into laboratory workflows, reducing manual effort and supporting consistent, standards-based output.…

Read more →

Webcast Recap: Drugs & Trials for Cancer Diagnostics

Mar 5, 2020

Introducing Drugs & Trials for Cancer Diagnostics VSClinical offers enormous simplicity and consistency in evaluating biomarkers and providing treatment options. Last month, we announced our newest feature to now include the automated collection of relevant clinical trials. The new capability was unveiled in our “Introducing Drugs & Trials for Cancer…

Read more →

VarSeq Cancer Gene Panel Tutorial

Mar 3, 2020

At Golden Helix, we want our new users to hit the ground running with VarSeq and not spend oodles of time getting started building and automating their workflows. To achieve this goal, our team has generated blogs, webcasts, and tutorials that explain and demonstrate workflows that are possible with VarSeq.…

Read more →

Customer Publications Throughout February 2020

Feb 27, 2020

Our customers are making great contributions to human research and precision medicine every month! In February 2020, VarSeq’s Clinical Suite dominated the published works citing Golden Helix. It is an honor for us to be at the forefront of so many important genetic investigations and we appreciate the efforts of…

Read more →

Powerful Cohort Analysis with VarSeq’s Count Alleles Algorithm

Feb 25, 2020

Although VarSeq is intentionally designed to be a clinical NGS analysis pipeline tool able to run a handful or even single samples through, we have many users who run large cohort style studies with the tool as well. One common use is to compare case/control data to isolate variants shared…

Read more →

VarSeq Copy Number Variant Caller Tutorial

Feb 20, 2020

Since the initial release of the copy number variant algorithms in VarSeq, our team has created a variety of content to help users get started with building their copy number variant projects. In our webcast library, you can find a few of our recent webcasts in 2019 covering CNV workflows…

Read more →

2020 Abstract Competition Winners

Feb 18, 2020

We would like to thank everyone who entered our 2020 Abstract Competition. It is wonderful to read about the different ways Golden Helix software is being applied around the world. It is our pleasure to announce this year’s winners! First Place: Dr. Robert Hamilton and Priyanka Kugamoorthy – SickKids Yearly…

Read more →

Cyber Security Strategies for NGS Testing Labs: Part IV

Feb 13, 2020

Golden Helix is in a unique position to provide a secure on-premise analysis solution. This capability is based on two enablers. First, we build our software solutions from scratch and from the ground-up with the assumption that it should run on any operating system and potentially behind firewalls or even without internet access. Second, we provide…

Read more →

Golden Helix Recognized as one of the Top 60 Genetics Blogs on the Web

Feb 11, 2020

We are incredibly grateful to be recognized as one of the Top 60 Genetics Blogs on the Web by Feedspot. Our team is dedicated to educating our readers on how our solutions can help enable precision medicine, and we are so honored to have received this recognition.  On our blog, you will…

Read more →

Cyber Security Strategies for NGS Testing Labs: Part III

Feb 6, 2020

Cyber security threats to organizations are more diverse and dangerous than ever, ranging from curious teenagers testing their skills to insider threats and state-sponsored hackers. On the highest-end, some state-financed actors extend their reach as far as possible into foreign countries. Motivation and intentions might vary, but the outcome for the targeted…

Read more →

Updated GRCh38 VarSeq Project Templates

Feb 4, 2020

As many of our users know, GRCh38 VarSeq project templates come preloaded with the software and are designed to give users a baseline workflow to streamline their NGS analysis. These templates are tailored for various applications including tumor-normal, trios, cancer and hereditary gene panels, and ACMG Guidelines workflows. The templates…

Read more →

Cyber Security Strategies for NGS Testing Labs: Part II

Jan 30, 2020

Data and cyber security breaches are a fact of life. Organizations are aware of the threats and putting their best efforts up to prevent them as much as possible. Industries across the entire spectrum have been exposed in recent years. I will go through a few examples to show how pervasive…

Read more →

Customer Publications Throughout January 2020

Jan 28, 2020

January 2020 has started strong for Golden Helix customers who are engaged in research projects! We are delighted to see so many publications in January 2020 citing our products. As always, we are proud to be a part of these scientific discoveries as well as many others, too numerous to…

Read more →

Customizing Your VSClinical Workflow: Part II

Jan 27, 2020

In the first part of this series, we covered how VarSeq supports customizing ACMG guidelines in VSClinical to streamline the clinical analysis workflow. VSClinical’s various customization parameters within the ACMG Guidelines workflow includes the choice of how the internal knowledge base of previous variant interpretations are stored and what considerations…

Read more →

Cyber Security Strategies for NGS Testing Labs: Part I

Jan 23, 2020

Hospitals and testing labs are undergoing a digital transformation like any other business in our time. They deal with personal data in categories with the highest level of security requirements: personal identity and medical records. The architecture chosen to store and analyze this data is critical to provide the best…

Read more →

Introducing Drugs and Trials for Cancer Diagnostics

Jan 23, 2020

When interpreting a variant using the AMP guidelines for somatic variant interpretation, clinicians must determine whether the variant can be considered a biomarker that affects clinical care by predicting sensitivity, resistance, or toxicity to a specific therapy. Such a determination requires the investigation of multiple evidence sources, including clinical trials,…

Read more →

Customizing Your VSClinical Workflow: Part I

Jan 14, 2020

Clinical labs offer a unique and sophisticated product that is performed repeatedly with high standards of quality. VarSeq was developed to provide labs with the customization required for clinical genetic tests in a repeatable workflow. On top of this, VSClinical offers additional parameters and choices that can be made when…

Read more →